Saratoga Advantage Trust: Health & Biotechnology Portfolio - Class I (SBHIX)
The Saratoga Advantage Trust: Health & Biotechnology Portfolio - Class I (SBHIX) is a mutual fund that focuses on investing in companies within the health and biotechnology industries. This fund aims to provide investors with long-term capital appreciation by selecting companies with strong growth potential and innovative products or services in the healthcare and biotech sectors. As a Class I fund, it is typically only available to institutional investors and has a higher minimum investment requirement. With a diverse portfolio of companies in these high-growth industries, SBHIX offers investors the potential for significant returns while also diversifying their investment portfolio.
SBHIX Mutual Fund Chart & Stats
- Previous Close
- $30.76
- Total Liabilities
- $61.52K
- Holding Count
- 29
- Brand
- Saratoga Advantage Trust
- Total Assets
- 11.62M
- Shares Outstanding
- N/A
- 52-Week Range
- $24.95 - $31.56
SBHIX Mutual Fund News
SBHIX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| JAZZJazz Pharmaceuticals | 5.95% |
| AMGNAmgen Inc | 5.83% |
| MCKMcKesson Corporation | 5.29% |
| CAHCardinal Health | 5.14% |
| UTHRUnited Therapeutics Corp. | 5.12% |
| CORCencora, Inc. | 4.71% |
| REGNRegeneron Pharmaceuticals | 4.63% |
| EXELExelixis | 4.47% |
| JNJJohnson & Johnson | 4.19% |
| NVSNovartis AG | 4.13% |
| Total | 49.47% |
Recently Viewed
No data currently available






